AREV Stock Overview
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
AREV Life Sciences Global Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.09 |
52 Week High | CA$0.27 |
52 Week Low | CA$0.065 |
Beta | 2.62 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | -35.71% |
3 Year Change | 28.57% |
5 Year Change | -95.71% |
Change since IPO | -94.23% |
Recent News & Updates
Shareholder Returns
AREV | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 0% | 4.7% | 0.2% |
1Y | -35.7% | 39.5% | 9.0% |
Return vs Industry: AREV underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: AREV underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
AREV volatility | |
---|---|
AREV Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 13.5% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.5% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: AREV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AREV's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Mike Withrow | https://www.arevlifesciences.com |
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company’s CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles. Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets.
AREV Life Sciences Global Corp. Fundamentals Summary
AREV fundamental statistics | |
---|---|
Market cap | CA$2.86m |
Earnings (TTM) | -CA$1.02m |
Revenue (TTM) | CA$183.89k |
15.5x
P/S Ratio-2.8x
P/E RatioIs AREV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AREV income statement (TTM) | |
---|---|
Revenue | CA$183.89k |
Cost of Revenue | CA$15.66k |
Gross Profit | CA$168.23k |
Other Expenses | CA$1.19m |
Earnings | -CA$1.02m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.032 |
Gross Margin | 91.48% |
Net Profit Margin | -555.81% |
Debt/Equity Ratio | -4.4% |
How did AREV perform over the long term?
See historical performance and comparison